Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Plos One
|
August 24, 2023
Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Akash Malhotra, Ryan Thompson, Margaretha De Vos, et al.
Plos One
|
December 26, 2024
Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Akash Malhotra, Ryan Thompson, Margaretha De Vos, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Optimal processing of tongue swab samples for Mycobacterium tuberculosis detection by the Xpert MTB/RIF Ultra assay
Gayatri Shankar Chilambi, Robert Reiss, Naranjargal Daivaa, et al.
Microbiology Spectrum
|
January 28, 2025
Optimal processing of tongue swab samples for <i>Mycobacterium tuberculosis</i> detection by the Xpert MTB/RIF Ultra assay
Gayatri Shankar Chilambi, Robert Reiss, Naranjargal Daivaa, et al.
The Journal of Molecular Diagnostics : JMD
|
October 15, 2022
Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization-Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid
Anura David, Margaretha de Vos, Lesley Scott, et al.
Briefings in Bioinformatics
|
December 28, 2021
Detection of minor variants in Mycobacterium tuberculosis whole genome sequencing data
Sander N Goossens, Tim H Heupink, Elise De Vos, et al.
The Cochrane Database of Systematic Reviews
|
May 18, 2022
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
Samantha Pillay, Karen R Steingart, Geraint R Davies, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 2, 2021
Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance
Anzaan Dippenaar, Brigitta Derendinger, Tania Dolby, et al.
Scientific Reports
|
February 16, 2020
Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk
Rouxjeane Venter, Stephanie Minnies, Brigitta Derendinger, et al.
Advances in Pharmacological and Pharmaceutical Sciences
|
July 9, 2021
Antimycobacterial Activity, Synergism, and Mechanism of Action Evaluation of Novel Polycyclic Amines against <i>Mycobacterium tuberculosis</i>
Erika Kapp, Jacques Joubert, Samantha L Sampson, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Plos One
|
August 24, 2023
Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Akash Malhotra, Ryan Thompson, Margaretha De Vos, et al.
Plos One
|
December 26, 2024
Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Akash Malhotra, Ryan Thompson, Margaretha De Vos, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Optimal processing of tongue swab samples for Mycobacterium tuberculosis detection by the Xpert MTB/RIF Ultra assay
Gayatri Shankar Chilambi, Robert Reiss, Naranjargal Daivaa, et al.
Microbiology Spectrum
|
January 28, 2025
Optimal processing of tongue swab samples for <i>Mycobacterium tuberculosis</i> detection by the Xpert MTB/RIF Ultra assay
Gayatri Shankar Chilambi, Robert Reiss, Naranjargal Daivaa, et al.
The Journal of Molecular Diagnostics : JMD
|
October 15, 2022
Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization-Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid
Anura David, Margaretha de Vos, Lesley Scott, et al.
Briefings in Bioinformatics
|
December 28, 2021
Detection of minor variants in Mycobacterium tuberculosis whole genome sequencing data
Sander N Goossens, Tim H Heupink, Elise De Vos, et al.
The Cochrane Database of Systematic Reviews
|
May 18, 2022
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
Samantha Pillay, Karen R Steingart, Geraint R Davies, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 2, 2021
Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance
Anzaan Dippenaar, Brigitta Derendinger, Tania Dolby, et al.
Scientific Reports
|
February 16, 2020
Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk
Rouxjeane Venter, Stephanie Minnies, Brigitta Derendinger, et al.
Advances in Pharmacological and Pharmaceutical Sciences
|
July 9, 2021
Antimycobacterial Activity, Synergism, and Mechanism of Action Evaluation of Novel Polycyclic Amines against <i>Mycobacterium tuberculosis</i>
Erika Kapp, Jacques Joubert, Samantha L Sampson, et al.
Page
of 6